Related Experiment Video
Updated: Aug 8, 2026

IP-FCM: Immunoprecipitation Detected by Flow Cytometry
Published on: December 2, 2010
The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse
Philip R Taylor1, Matthew C Pickering, Marie H Kosco-Vilbois
1Sir William Dunn School of Pathology, Oxford University, South Parks Road, Oxford, GB.
Insights
The follicular dendritic cell marker FDC-M2 is identified as complement component C4. This finding reveals new insights into immune complex clearance and complement deposition in inflammatory diseases.
Area of Science:
- Immunology
- Complement System Biology
Background:
- Follicular dendritic cells (FDCs) are crucial for adaptive immunity.
- The FDC-M2 marker, recognized by mAb209, has been used to study FDCs.
- The precise identity and function of FDC-M2 have remained unclear.
Purpose of the Study:
- To identify the molecular nature of the murine FDC marker FDC-M2.
- To investigate the role of FDC-M2 in immune complex-mediated inflammation and clearance.
- To evaluate mAb209 as a tool for studying complement deposition in vivo.
Main Methods:
- Immunohistochemistry using mAb209 on wild-type and complement-deficient mice.
- Analysis of FDC-M2 distribution in various tissues, particularly at sites of inflammation.
- Comparison of immune complex deposition and clearance in different complement-deficient models.
Main Results:
- The FDC-M2 marker was identified as complement component C4.
- FDC-M2 (C4) was detected at sites of immune complex-mediated inflammation.
- Distinct populations of FDC-M2+ cells in the spleen, separate from FDCs, were involved in immune complex capture.
Conclusions:
- Monoclonal antibody mAb209 recognizes complement component C4, not solely an FDC-specific protein.
- mAb209 is a valuable tool for analyzing complement deposition and immune complex dynamics in vivo.
- The study reveals novel roles for FDC-M2+ cells in immune complex handling beyond traditional FDCs.
Abstract:
We have identified the murine follicular dendritic cell (FDC) marker, FDC-M2, recognized by monoclonal antibody mAb209, as complement component C4. Consistent with this, FDC-M2 was detectable at sites of immune complex-mediated inflammatory disease. Analysis of FDC-M2 distribution in complement-deficient mice highlighted the differences in immune complex clearance between these mice, andshowed that a population of uncharacterized FDC-M2+ reticular and perivascular cells in the spleen, distinct from FDC, are also involved in immune complex capture and possibly retention. These results demonstrate that mAb209, in addition to its role as an FDC marker, is a valuable reagent for the analysis of complement deposition in vivo.

